PAXLOVID: payments to doctors
Payments that named PAXLOVID as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $7.4M
- Providers
- 112,989
- Transactions
- 354,922
- Average per transaction
- $21
The per-transaction average — $21 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 112,989 providers the average total is $65, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Pfizer | $7,304,872 | 98.9% |
| Array Biopharma Inc | $34,695 | 0.5% |
| Pfizer Chile S.A. | $20,600 | 0.3% |
| PBG Puerto RICO LLC | $19,722 | 0.3% |
| Hospira, Inc. | $8,442 | 0.1% |
| PBG Puerto Rico LLC | $17 | 0.0% |